Skip to content

Advertisement

Acta Neuropathologica Communications

What do you think about BMC? Take part in

 ANC: Neuroscience of Disease

Featured video: Another mechanism for the initiation and progression of Parkinson's disease

A research team in the USA and China identifies a potential disease mechanism in the initiation and development of Parkinson’s disease. 

Read the full article here

Articles

  1. Content type: Research

      |  

    Authors: Veronica Hirsch-Reinshagen, Cyril Pottier, Alexandra M. Nicholson, Matt Baker, Ging-Yuek R. Hsiung, Charles Krieger, Pheth Sengdy, Kevin B. Boylan, Dennis W. Dickson, Marsel Mesulam, Sandra Weintraub, Eileen Bigio, Lorne Zinman, Julia Keith, Ekaterina Rogaeva, Sasha A. Zivkovic…

View all articles
View all articles

Featured article: Novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease

Dr. Finkelstein et al report the preclinical characterization of PBT434, a novel quinazolinone compound bearing a moderate affinity metal-binding motif, which is in development for Parkinsonian conditions.  

EUROTAU: Reflections on the Status Quo

A series of articles from the first EUROTAU meeting. 

EUROTAU is an innovative, collaborative research initiative established to tackle unanswered research questions and the mounting challenges posed by Tauopathies.

Editors-in-Chief

Werner Paulus, University of Münster, Germany
Johannes Attems, Newcastle University, UK

Aims and scope

Acta Neuropathologica Communications (ANC) focuses on the pathogenesis of neurological disease using experimental or human tissues, molecular, cellular, biological and morphological techniques.

Why publish with ANC?

  • No major revisions: only minor revisions are requested that can be performed (and have to be performed) within 3 weeks
  • Fast, thorough peer review: group of editors selected on the basis of their insightful, dedicated and prompt service
  • Rapid publication: publication within 2 months of submission
  • Inclusion in PubMed, PubMed Central and MEDLINE
  • Open access: enabling it to be read by a much larger set of readers, increasing its visibility
  • Competitive APC: flat article-processing charge, with no page limits, color figure charges or submission fees

Frequently Asked Questions

Our FAQs about the journal are answered 

Our commitment to excellent author service

ANC is committed to rapid publication. We aim to publish all research articles within 2 months of submission, subject to authors responding to requests within the required timeframe. If the publication of your article exceeds 2 months from submission, you may be entitled to a full waiver or discount of the article-processing charge on your next submission to the journal. This policy excludes manuscripts delayed for reasons outside of the Publisher's control, such as delays resulting from ethics-related issues or queries concerning your manuscript. All claims will be considered on a case-by-case basis. For further information or to make a claim, please contact editorial@actaneurocomms.org.  

Sister journal

ANC is sister journal to Acta Neuropathologica, a journal dedicated to the pathology and mechanisms of neurological disease.

Latest Tweets

Werner

Editors' quotes

"Acta Neuropathologica Communications is an open access, peer-reviewed online journal. Like our sister journal Acta Neuropathologica we focus on pathology and mechanisms of neurological disease. We publish high quality articles that do not require major manuscript revisions. We offer very fast turnaround times, publication of papers within two months following submission, enthusiastic editors, and a competitive article-processing charge. Try it out!"

Werner Paulus, co-Editor-in-Chief, ANC

Johannes

"Acta Neuropathologica Communications is a journal for researchers working on human neurological disease and has a focus on neuropathology. However, since we believe that an interdisciplinary approach is highly valuable to advance the field, our journal is not restricted to classical neuropathological articles. Therefore, we also welcome high-quality submissions from other disciplines as long as they do ultimately aim to advance our understanding of human neurological disease. We try our best to help you with the submission process and in case of any questions do not hesitate to contact the Editors-in-Chief directly."

Johannes Attems, co-Editor-in-Chief, ANC

Advertisement

Logo

2016 Journal Metrics

Advertisement